A Simple Nonviral Method to Generate Human Induced Pluripotent Stem Cells Using SMAR DNA Vectors.
Anna HartleyLuisa BurgerCornelia L WincekLieke DonsTracy LiAnnabel GrewenigToros TaşgınManuela UrbanAlicia Roig-MerinoMehrnaz GhazviniRichard P HarbottlePublished in: Genes (2024)
Induced pluripotent stem cells (iPSCs) are a powerful tool for biomedical research, but their production presents challenges and safety concerns. Yamanaka and Takahashi revolutionised the field by demonstrating that somatic cells could be reprogrammed into pluripotent cells by overexpressing four key factors for a sufficient time. iPSCs are typically generated using viruses or virus-based methods, which have drawbacks such as vector persistence, risk of insertional mutagenesis, and oncogenesis. The application of less harmful nonviral vectors is limited as conventional plasmids cannot deliver the levels or duration of the factors necessary from a single transfection. Hence, plasmids that are most often used for reprogramming employ the potentially oncogenic Epstein-Barr nuclear antigen 1 (EBNA-1) system to ensure adequate levels and persistence of expression. In this study, we explored the use of nonviral SMAR DNA vectors to reprogram human fibroblasts into iPSCs. We show for the first time that iPSCs can be generated using nonviral plasmids without the use of EBNA-1 and that these DNA vectors can provide sufficient expression to induce pluripotency. We describe an optimised reprogramming protocol using these vectors that can produce high-quality iPSCs with comparable pluripotency and cellular function to those generated with viruses or EBNA-1 vectors.
Keyphrases
- induced pluripotent stem cells
- epstein barr virus
- induced apoptosis
- gene therapy
- escherichia coli
- circulating tumor
- poor prognosis
- cell free
- cell cycle arrest
- single molecule
- randomized controlled trial
- klebsiella pneumoniae
- diffuse large b cell lymphoma
- oxidative stress
- endoplasmic reticulum stress
- signaling pathway
- cell proliferation
- endothelial cells
- multidrug resistant
- gene expression
- cell fate